Temple University Health System’s preparations for and treatment of patients amidst the coronavirus pandemic continue to be part of the media’s COVID-19 coverage.
- Tony S. Reed, MD, MBA, Executive Vice President and Chief Medical Officer of Temple University Health System, spoke with NBC10 about the Pfizer coronavirus vaccine as well as the others still in development, including Janssen’s investigational COVID-19 vaccine candidate. Temple University Hospital is a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 ENSEMBLE trial to evaluate the safety and efficacy of the vaccine.
- 6ABC and the Philadelphia Tribune interviewed Dr. Reed on the increasing number of COVID-19 cases and hospitalizations as well as the importance of precautions such as wearing a mask and social distancing.
- John Lasky, JD, Executive Vice President and Chief Human Resources Officer of Temple University Health System, provided perspective about Temple’s decision to join TIAA and Savi to offer employees a solution to reduce monthly student loan payments and remain in compliance with the Public Service Loan Forgiveness Program during the coronavirus pandemic. Outlets including Markets Insider, Morningstar and others featured the news.
- Jamie Garfield, MD, Associate Professor of Thoracic Medicine and Surgery and Core Clinical Educator at the Lewis Katz School of Medicine at Temple University and Director of Quality and Improvement and Patient Safety, Core Clinical Faculty, for the Internal Medicine Residency at Temple University Hospital, joined NBC10 to discuss the increasing number of COVID-19 cases and hospitalizations as well as what to keep in mind as the holidays approach.
- Jennifer L. Aldrich, MD, Associate Professor of Clinical Medicine at the Lewis Katz School of Medicine at Temple University, offered insight to the Philadelphia Gay News about the COVID-19 pandemic, including the importance of getting a flu shot and continuing to practice precautions as the holidays get closer.
- Mari Siegel, MD, a palliative care physician at Temple University Hospital, and a patient reflected on the importance of palliative care during the coronavirus pandemic for an article in the Jewish Exponent.
- Servio H. Ramirez, PhD, Professor of Pathology and Laboratory Medicine at the Lewis Katz School of Medicine at Temple University (LKSOM), joined KYW Newsradio to discuss new research to be published in the December print issue of the journal Neurobiology of Disease which is the first to show that the spike proteins that extrude from SARS-CoV-2 promote inflammatory responses on the endothelial cells that form the blood-brain barrier and can cause this barrier to become “leaky,” potentially disrupting the delicate neural networks within the brain. Dr. Ramirez is the principal investigator on the study. Tetyana P. Buzhdygan, PhD, is a postdoctoral fellow and first author on the report, and Allison M. Andrews, PhD, Assistant Professor in the Department of Pathology and Laboratory Medicine at LKSOM, is a co-author.
- Arundathi Jayatilleke, MD, Associate Professor of Medicine at the Lewis Katz School of Medicine at Temple University and Director of the Rheumatology Fellowship Program at Temple University Hospital, spoke about the use of telemedicine during the COVID-19 pandemic and its future during the American College of Rheumatology’s virtual conference. Dr. Jayatilleke emphasized the importance of reviewing telemedicine practices and data (and having more in-depth studies) as well as early results that have shown its effectiveness for patients with gout and rheumatoid arthritis. Dr. Jayatilleke’s insight was featured on the Arthritis Foundation’s blog.
- Kendra A. Mendez, MD, Instructor of Emergency Medicine at the Lewis Katz School of Medicine at Temple University, presented a study at the American College of Emergency Physicians’ 2020 “Unconventional” online congress on the initial imaging of possible COVID-19 patients reporting to the emergency department and conducting that screening by ultrasound vs. X-ray. Dr. Mendez discussed the findings with Medscape.